AN2 Therapeutics, Inc. funding
AN2 Therapeutics, Inc., a pharmaceuticals company based in Menlo Park, CA, filed a Form D with the SEC on March 25, 2026 and reported $40M raised.
Amount raised$40M
Offering size$40M
Filed with the SECMarch 25, 2026
First saleMarch 10, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationMenlo Park, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far16
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 25
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology